Lung carcinoma imaging using a synthetic laminin derivative radioiodinated peptide YIGSR

Journal of Nuclear Medicine

Volumn 38, Issue 12, 1997, Pages 1940-1944

  Koliakos, George ^a,b   Trontzos, Christos ^a   Kouzi Koliakos, Kokkona ^a   Kanellaki, Mary ^a   Grammaticos, Philippos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

Extracellular matrix; Laminin peptides; Metastasis; Radiolabeled peptide; Receptors; Tumor imaging

Indexed keywords

LAMININ; LAMININ RECEPTOR; TYROSYL ISOLEUCYL GLYCYL SERYL ARGININE I 131; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CELL SURFACE; COLLIMATOR; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EXTRACELLULAR MATRIX; ISOTOPE LABELING; LUNG CARCINOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCINTILLATION CAMERA; SPLEEN;

ANIMALS; AUTORADIOGRAPHY; CARCINOMA, LEWIS LUNG; IODINE RADIOISOTOPES; LAMININ; LUNG; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES; RADIOPHARMACEUTICALS;

EID: 0031474652     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Buck CA, Horwitz AF. Cell surface receptors for extracellular matrix molecules. Ann Rev Cell Biol 1987;3:179-205.
2. Fields GB. Synthetic peptides and tumor cell metastasis. Pept Res 1993;6:115-120.
3. Timpl R, Dziadek M. Structure development and molecular pathology of basement membranes. Int Rev Exp Pathol 1986;29:1-112.
4. Liotta LA, Rao CN, Wiener VM. Biochemical interactions of tumor cells with basement membrane. Annu Rev Biochem 1986;55:1037-1055.
5. Mercurio AM. Laminin: multiple forms, multiple receptors. Curr Opin Cell Biol 1990;2:845-849.
6. Koliakos GG, Tsilibary EC, Charonis AS. A melanoma cell surface laminin binding protein with apparent Mr 90000. Connect Tissue Res 1991;26:167-180.
7. Terranova V, Liotta LA, Russo RP, Martin GR. Role of laminin in the attachment and metastasis of tumor cells. Cancer Res 1982;42:2265-2269.
8. Daneker GW Jr, Piazza AJ, Steele GD Jr, Mercurio AM. Relationship between extracellular matrix interactions and degree of differentiation in human colon carcinoma cell lines. Cancer Res 1989;49:681-686.
9. Castronovo V, Sobel ME. Laminin and fibronectin increase the steady-state level of the 67kD high affinity metastasis-associated laminin receptor mRNA in human cancer cells. Biochem Biophys Res Commun 1990;168:1110-1117.
10. Alino SF, Unda FJ, Perez-Yarza G. Laminin surface binding sites and metastatic potential of 3LL tumor cells, increased by indomethacin. Biochem Biophys Res Commun 1990;167:731-738.
11. Graf J, Ogle RC, Robey FA, et al. A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the 67000 laminin receptor. Biochemistry 1987;26:6896-6900.
12. Iwamoto Y, Robey FA, Graf J, et al. YIGSR, a synthetic laminin pentapeptide inhibits experimental metastasis formation. Science 1987;238:1132-1134.
13. Kramer RH, Gonzales R, Nicolson GL. Metastatic tumor cells adhere preferentially to the extracellular matrix underlying vascular endothelial cells. Int J Cancer 1980;26: 639-645.
14. Terranova VP, Rao CN, Kalebic T, Margulies IM, Liotta LA. Laminin receptor on human breast carcinoma cells. Proc Natl Acad Sci USA 1983;80:444-448.
15. Yamamura K, Kibbey MC, Kleinman HK. Melanoma cells selected for adhesion to laminin peptides have different malignant properties. Cancer Res 1993;53:423-428.
16. Hunter WM, Greenwood FC. Preparation of iodine-131-labeled human growth hormone of high specific activity. Nature 1962;227:495-496.
17. 99mTc-IKVAV localizes to the lung. Biochim Biophys Acta 1993;1182:197-204.
18. Kaneda Y, Yamamoto S, Kihira T, et al. Synthetic cell-adhesive laminin peptide YIGSR conjugated with polyethyleneglycole has improved antimetastatic activity due to a longer half-life in blood. Invasion Metastasis 1995;15:156-162.
19. Fialkow PJ. Clonal origin of human tumors. Biochim Biophys Acta 1976;458:283-321.
20. Fidler IJ. Biological diversity in metastatic neoplasms: origins and implications. Science 1982;217:998-1003.
21. Hepner GH. Tumor heterogeneity. Cancer Res 1984;44:2259-2265.
22. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-895.
23. Liotta LA, Kleineman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 1974;34:997-1004.
24. Terranova VP, Hujanen ES, Martin GR. Basement membrane and the invasive activity of metastatic tumor cells. J Natl Cancer Inst 1986;77:311-316.
25. Fishman AJ, Khaw BA, Strauss HW. Quo vadis radioimmune imaging. J Nucl Med 1989;30:1911-1915.
26. Iwamoto Y, Nomizu M, Yamada-Y, Ito Y, Tanaka K, Sugioka Y. Inhibition of angiogenesis, tumour growth and experimental metastasis of human fibrosarcoma cells HT1080 by a multimeric form of the laminin sequence Tyr-Ile-Gly-Ser-Arg (YIGSR). Br J Cancer 1996;73:589-595.
27. Hill RP. Metastasis. In: Tannock IF, Hill RP, eds. The basic science of oncology, 2nd ed. New York: McGraw-Hill; 1992:178-195.
28. Hanna N. Role of natural killer cells in host defense against cancer metastasis. In: Nicolson GL, Milas L, eds. Cancer invasion and metastasis: biologic and therapeutic aspects. New York: Raven Press; 1984;309-319.
29. Greenberg AH, Egan SE, Jarolin L, et al. Natural killer cell regulation of implantation and early lung growth of H-ras-transformed 10T1/2fibroblasts in mice. Cancer Res 1987;47:4801-4805.